Clinical trial
A Phase 1 Study of MORAb-202 in Subjects With Solid Tumors
NCT03386942 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of MORAb-202 in Subjects With Solid Tumors
- Lead sponsor
- Eisai Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 28, 2017
- Completion date
- October 26, 2022
- Enrollment
- 82 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumors